Verastem, Inc. (VSTM) - Dilution Analysis

10-Q filing | 87.9M shares outstanding

8-K filing: Verastem, Inc. completed a public offering involving the issuance and sale of 8,543,794 shares of common stock, pre-funded warrants to purchase up to 3,870,000 shares of common stock, and an additional 1,862,069 shares of common stock upon the exercise of the underwriter's option, at a price of $7.25 per share and $7.2499 per pre-funded warrant, resulting in net proceeds of approximately $96.9 million.

10-Q filing | 73.2M shares outstanding

S-3/A filing: The company is filing an S-3/A to register the offer and sale of common stock with an aggregate offering price of up to $100,000,000 through an "at-the-market" offering, along with shelf registration of common stock, preferred stock, warrants, and debt securities up to $300,000,000.

10-Q filing | 66.1M shares outstanding

10-Q filing | 54.2M shares outstanding

S-3 filing: This is an S-3 filing to register the resale of common stock and common stock issuable upon the exercise of pre-funded warrants by selling stockholders.

8-K filing: Verastem, Inc. entered into a Securities Purchase Agreement to sell 3,429,287 shares of common stock at $7.00 per share and pre-funded warrants to purchase 7,285,713 shares at $6.9999 per warrant in a private placement expected to close on April 28, 2025, with gross proceeds of approximately $75 million. ($75.0M proceeds)

S-3 filing: This S-3 filing registers up to 1,416,939 shares of common stock for resale by selling stockholders.

10-K filing | 44.8M shares outstanding

8-K filing: Verastem, Inc. sold 1,416,939 shares of its common stock to Oberland Funds and affiliates at a price of $5.2931 per share on January 13, 2025.

10-Q filing | 40.3M shares outstanding

10-Q filing | 26.9M shares outstanding

8-K filing: Verastem, Inc. announced an underwritten offering of 13,333,334 shares of common stock and accompanying warrants, as well as pre-funded warrants to purchase up to 5,000,000 shares of common stock and accompanying warrants, with expected net proceeds of approximately $51.1 million.

10-Q filing | 26.8M shares outstanding

10-K filing | 25.3M shares outstanding

10-Q filing | 26.8M shares outstanding

S-3 filing: The company intends to offer and sell, from time to time, any combination of common stock, preferred stock, warrants, and debt securities up to $300,000,000 in the aggregate.

10-Q filing | 25.2M shares outstanding

8-K filing: Verastem, Inc. completed an underwritten offering of 7,181,409 shares of common stock at $9.75 per share and pre-funded warrants to purchase 1,538,591 shares at $9.749 per warrant. The underwriters exercised their option to purchase an additional 1,308,000 shares.

8-K filing: Stock split 1-for-12 | Outstanding: 200,679,000 → 16,716,560

10-Q filing | 200.7M shares outstanding

S-3/A filing: This S-3/A filing relates to the resale or disposition of 1,200,000 shares of Series B convertible preferred stock and up to 50,838,840 shares of common stock upon conversion of the Series B preferred stock by selling stockholders.

S-3 filing: This is an S-3 filing for the resale or other disposition of up to 2,144,160 shares of Series B convertible preferred stock and up to 90,838,839 shares of common stock upon conversion of Series B Preferred Stock by selling stockholders.

10-K filing | 193.7M shares outstanding

8-K filing: Verastem, Inc. entered into a Securities Purchase Agreement to sell and issue up to 2,144,160 shares of Series B convertible preferred stock in a private placement in two tranches, with the first tranche closing on January 27, 2023, and the second tranche dependent on certain market conditions. ($60.0M proceeds)

8-K filing: Verastem, Inc. exchanged 10,000,000 shares of common stock for 1,000,000 shares of newly designated Series A convertible preferred stock with Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS LP and MSI BVF SPV, LLC on November 4, 2022. Following the Exchange, the Company will have 200,090,850 shares of Common Stock outstanding and 1,000,000 shares of Preferred Stock outstanding, which are convertible into 10,000,000 shares of Common Stock.

10-Q filing | 197.2M shares outstanding

10-Q filing | 186.5M shares outstanding

10-Q filing | 186.3M shares outstanding

10-K filing | 174.4M shares outstanding

10-Q filing | 179.9M shares outstanding

10-Q filing | 172.1M shares outstanding

10-Q filing | 171.7M shares outstanding

10-K filing | 170.5M shares outstanding

10-Q filing | 80.1M shares outstanding

10-Q filing | 80.1M shares outstanding

10-Q filing | 162.5M shares outstanding

S-3/A filing: This S-3/A filing relates to the resale or other disposition from time to time of up to 46,511,628 shares of common stock by the selling stockholders.

S-3 filing: This S-3 filing relates to the resale of up to 46,511,628 shares of common stock by selling stockholders.

10-K filing | 148.4M shares outstanding